Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 9;6(2):121-125.
doi: 10.1002/jpr3.70016. eCollection 2025 May.

DGAT-1 deficiency: Congenital diarrhea and dietary treatment

Affiliations

DGAT-1 deficiency: Congenital diarrhea and dietary treatment

Clemens Gardemann et al. JPGN Rep. .

Abstract

DGAT-1 (Diacylglycerol Acyltransferase-1) deficiency is an autosomal recessive disorder which causes severe impairment in lipid absorption. We report a case of an infant suffering from persistent diarrhea starting at the age of four weeks. Further investigations identified DGAT-1 deficiency as underlying cause. A treatment plan was developed which included a very-low fat diet administered as infant formula, essential fatty acid supplementation, C8 medium chain triglycerides- and fat-soluble vitamin supplementations. The patient was put into full remission after administration of the treatment plan and weight curves normalized at the 50th percentile at the age of 24 months. Intermittent episodes of loose stools were due to an excessive intake of fructose via extensive fruit consumption. DGAT-1 deficiency is a rare genetic disease which leads to congenital diarrhea and is especially dangerous in infancy. Our treatment plan put the patient into full remission showing that C8 MCT oil should be preferred over treatment with C8/C10 mixtures.

Keywords: DGAT‐1; MCT; congenital diarrhea; gastroenterology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Left: Patient at the age of 6 months showing severe dystrophy, Middle: At the age of 9 months after initiating treatment, Right: Skin lesion of the patient caused by essential fatty acid deficiency
Figure 2
Figure 2
Chromatograms of fatty acid profile of the phoshpholipid compositions in serum pre (pink) and post (black) treatment with omega 3/6 supplement. DHA, docosahexaenoic acid

References

    1. Haas JT, Winter HS, Lim E, et al. DGAT1 mutation is linked to a congenital diarrheal disorder. J Clin Invest. 2012;122(12):4680‐4684. - PMC - PubMed
    1. Amin NB, Saxena AR, Somayaji V, Dullea R. Inhibition of diacylglycerol acyltransferase 2 versus diacylglycerol acyltransferase 1: potential therapeutic implications of pharmacology. Clin Ther. 2023;45(1):55‐70. - PubMed
    1. Deolet E, Callewaert B, Geldof J, et al. Apoptotic enteropathy, gluten intolerance, and IBD‐like inflammation associated with lipotoxicity in DGAT1 deficiency–related diarrhea: a case report of a 17‐year‐old patient and literature review. Virchows Arch. 2022;481(5):785‐791. - PubMed
    1. Gluchowski NL, Chitraju C, Picoraro JA, et al. Identification and characterization of a novel DGAT1 missense mutation associated with congenital diarrhea. J Lipid Res. 2017;58(6):1230‐1237. - PMC - PubMed
    1. van Rijn JM, Ardy RC, Kuloğlu Z, et al. Intestinal failure and aberrant lipid metabolism in patients with DGAT1 deficiency. Gastroenterology. 2018;155(1):130‐143.e15. - PMC - PubMed

LinkOut - more resources